EP Patent

EP2220116A1 — Compositions and methods for the therapy and diagnosis of influenza

Assigned to Theraclone Sciences Inc · Expires 2010-08-25 · 16y expired

What this patent protects

The present invention provides novel human anti-influenza antibodies binding to conformational determinants of an M2 homotetramer and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.

USPTO Abstract

The present invention provides novel human anti-influenza antibodies binding to conformational determinants of an M2 homotetramer and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.

Drugs covered by this patent

Patent Metadata

Patent number
EP2220116A1
Jurisdiction
EP
Classification
—
Expires
2010-08-25
Drug substance claim
No
Drug product claim
No
Assignee
Theraclone Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.